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Abstract
Background: Cystic fibrosis (CF), caused by reduced CFTR function, includes severe sinonasal disease which may predispose
to lung disease. Newly developed CF pigs provide models to study the onset of CF pathophysiology. We asked if glands
from pig nasal turbinates have secretory responses similar to those of tracheal glands and if CF nasal glands show reduced
fluid secretion.
Methodology/Principal Findings: Unexpectedly, we found that nasal glands differed from tracheal glands in five ways,
being smaller, more numerous (density per airway surface area), more sensitive to carbachol, more sensitive to forskolin,
and nonresponsive to Substance P (a potent agonist for pig tracheal glands). Nasal gland fluid secretion from newborn
piglets (12 CF and 12 controls) in response to agonists was measured using digital imaging of mucus bubbles formed under
oil. Secretion rates were significantly reduced in all conditions tested. Fluid secretory rates (Controls vs. CF, in pl/min/gland)
were as follows: 3 mM forskolin: 9.262.2 vs. 0.660.3; 1 mM carbachol: 143.5635.5 vs. 52.2610.3; 3 mM forskolin + 0.1 mM
carbachol: 25.865.8 vs. CF 4.560.9. We also compared CF
DF508/DF508 with CFTR
-/- piglets and found significantly greater
forskolin-stimulated secretion rates in the DF508 vs. the null piglets (1.460.8, n=4 vs. 0.260.1, n=7). An unexpected age
effect was also discovered: the ratio of secretion to 3 mM forskolin vs. 1 mM carbachol was ,4 times greater in adult than in
neonatal nasal glands.
Conclusions/Significance: These findings reveal differences between nasal and tracheal glands, show defective fluid
secretion in nasal glands of CF pigs, reveal some spared function in the DF508 vs. null piglets, and show unexpected age-
dependent differences. Reduced nasal gland fluid secretion may predispose to sinonasal and lung infections.
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Introduction
Cystic fibrosis (CF) occurs when CFTR anion channels, which
are especially important in the functioning of ion transporting
epithelia, are missing or defective. An elevated transepithelial
difference across the nasal epithelium was the first electrophysi-
ological signature of an ion transport defect in CF [1]. That
finding led to extensive research on electrolyte transport defects in
CF respiratory epithelia and glands. One goal of that research is to
understand how altered epithelial ion and fluid transport
predisposes the respiratory system to chronic bacterial infections,
which are presently the most significant clinical feature of CF.
Almost all CF patients have upper airway abnormalities, and
,50% have chronic rhinosinusitis (CRS) and/or nasal polyps [2].
In the non-CF population, CFTR mutations on one chromosome
predispose to CRS [3], sometimes including bacterial biofilms on
the nasal mucosa [4]. It is hypothesized that sinonasal bacterial
infections can seed the lower airways, based on evidence for earlier
onset of upper airway infections and concordance between
sinonasal and lower airway pathogens [5,6,7,8,9,10,11,12,13].
Nasal epithelium is easier to access than the lower airways, for
which it often serves as a surrogate to assess CFTR function in
humans, in vivo [14,15,16], or in tissue culture [17,18,19].
In the trachea and bronchi submucosal glands express CFTR
[20], and are functionally important in antimicrobial defense;
ferret tracheal xenografts lacking submucosal glands produce less
lysozyme and are more prone to infection than xenografts with
glands [21]. Mucus accumulation and obstruction of submucosal
glands, secondary to decreased fluid secretion, has been suggested
to be a contributing factor to the pathophysiology of patients with
CF [22,23,24,25], and in CF human bronchi, the submucosal
glands lack or have reduced fluid secretion in response to multiple
agonists [26,27,28,29]. Nasal glands have only rarely been studied
directly in CF subjects, but in an important exception, gland
secretion in response to pilocarpine was reduced and more acidic
in nasal biopsy tissue from relatively healthy CF subjects [30].
However, the links between the ion transport dysfunctions of
human CF airway glands and surface epithelia and CF lung
disease remain obscure.
Animal models that mimic human CF are a potential solution to
this research bottleneck. Among animals, pig airways share many
features with human airways [31] and CF pigs, both CFTR
-/- [32]
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DF508/DF508 [33] have now been generated and shown
to share many features of CF organ-level disease [34,35,36,37],
including a defect in tracheal host defense against bacterial
infections [37], and defective tracheal gland secretion [38].
Because of severe meconium ileus, most CF piglets are euthanized
shortly after birth. However, a few pigs that survived up to 6
months after intestinal bypass surgery had airways infected with
multiple organisms and displayed mucus accumulation and airway
remodeling [37]. Rhinosinusitis in the CF pig has not yet been
reported, but its nasal epithelium exhibited defective chloride
transport [32].
We discovered several novel features of nasal submucosal glands
and have also shown differences between control and CF glands,
and between glands having CFTR
-/- and CFTR
DF508/DF508
genotypes. We also discovered marked, age-related differences in
the relative magnitude of forskolin and carbachol-stimulated
secretion.
Results
Size, density and secretory capacity of nasal vs. tracheal
glands as a function of age
Each nasal turbinate is attached to the lateral wall of the nasal
cavities and comprises superior and inferior scrolls (Figure 1A, C).
The extent of the turbinate mucosa used for measuring mucus
secretion from glands is indicated with the dotted lines in
Figure 1B, C.
When the turbinate mucosa is covered with an oil layer and
stimulated, the secretions from the turbinate submucosal glands
form dense arrays of mucus bubbles. In neonatal piglets, the
number and density of CF and WT glands did not appear to differ
based on counts of the mucus bubbles per unit area of turbinate
and submucosal gland histology (Figure 2A, B, F, G).
We compared the density of submucosal glands in the nasal
turbinates with those in the anterior trachea, and compared
neonateswithadults.Inthe areasofhighestglanddensity,measured
on the area indicated in Figure 1B, C, glands were ,3-fold more
abundant than in the anterior trachea (Figure 2D). Gland density
decreased with age both in nasal turbinates and in trachea,
consistent with the number of glands being fixed near the time of
birth [39], so that the same number of glands serves a larger surface
area (Figure 2D). The decline was greater in the trachea, where the
density in adults was ,15% of neonatal piglets, compared with
nasal turbinates, where the density in adults was ,33% of neonatal
piglets. Single gland secretion rates (in response to 1 mM carbachol)
showed an opposite trend (Figure 2E). In tracheal glands, secretion
rates of adults are roughly 5-fold greater than rates of 1-day old
piglets, while in nasal glands secretion rates of adults are roughly 4-
fold greater than rates of 1-day old piglets.
Although the number and volume of nasal glands appeared to be
unchanged by visual inspection of 3 samples of WT and CF
turbinates (Figure 2I, J, Figure S1), we did not quantify gland
volumes with morphometric analysis. Analysis of sectioned tracheas
was used by Meyerholz et al. to show that tracheal gland volume of
CF piglets was reduced by 31%–37% [36], and a similar reduction
might be present in the turbinate glands, although the CF pig nasal
cavity does not display the gross morphological changes that are
obviousuponvisualinspectionofthe trachea.Thereforesomeofthe
reduced secretory responsivenessof the CF glands might result from
decreased gland volume (see discussion).
CF piglets show reduced nasal gland fluid secretion in
response to forskolin
Tracheal submucosal glands of CF humans, pigs, mice and
ferrets have profound reductions in their secretory responses to
forskolin [26,38,40,41]. To determine if CF piglet nasal glands
were similarly impaired, we measured their responses to forskolin
stimulation (Figure 3). Average basal (unstimulated) secretion rates
were ,2 pl/min/gl in all genotypes (n=22). In WT nasal glands
forskolin significantly increased the secretion rate ,7-fold within
5 min (P,0.002, n=22). Secretion was sustained for at least
30 min (Figure 3A, gray symbols). In contrast, CF gland secretion
rates did not change significantly after forskolin (Figure 3A, black
symbols). CF nasal gland viability was established by showing
responsiveness to carbachol after the glands failed to respond to
two concentrations of forskolin (Figure 3B). Mean data for
forskolin experiments with 10 control piglets (8 WT + 2 Hz) and
12 CF piglets are shown in Figure 3C. The forskolin-stimulated
secretion rate in CF piglets (0.660.3 pl/min) did not differ
significantly from the basal rate (P=0.66) and was significantly
reduced relative to control piglets (9.262.2 pl/min; P,0.0003).
Comparison of CF
DF508/DF508 and CF
-/- piglet responses to
forskolin
We compared forskolin-stimulated nasal gland fluid secretion
from CF
DF508/DF508 vs. CF
-/- genotypes (Figure 3D, E). The mean
secretion rate for the CF
DF508/DF508 piglets was 1.460.8 pico-
liters/min/gland, n=4, 48 glands vs. 0.260.1 for CF
-/- piglets
(n=7, 75 glands, P,0.03). Most glands from either phenotype did
not respond to forskolin. To compare the two genotypes further,
we plotted results for 112 individual control glands and 123 CF
Figure 1. Gross anatomy of pig nasal cavity and turbinate. A, Cross-section of adult pig nose observed from caudal side. B, Ventral nasal
turbinate from right side of nasal cavity of adult pig, observed from medial side. Inset shows turbinate from a neonatal piglet. C, Cross-sectioned
turbinate showing superior and inferior scrolls. Dotted lines in B and C indicate convex medial side of ventral nasal turbinate where most submucosal
glands are located and where mucus bubbles were observed. Scale bars: 20 mm (A); 10 mm (B).
doi:10.1371/journal.pone.0024424.g001
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-/- and 48 from CF
DF508/DF508 pigs.
Overall, 46/123 (37%) of CF glands responded to forskolin, with
31/48 (65%) of the CF
DF508/DF508 glands responding vs. 15/75
(20%) were from the CF
-/- genotype. The average secretion rate of
the responding CF
DF508/DF508 glands was 1.6 fold higher than that
of the responding CF
-/- glands (Figure 3E).
Comparisons of tracheal vs. nasal glands and neonate
nasal vs. adult nasal glands revealed differential
responsiveness to agonists
We established dose-response relationships to carbachol and
forskolin in nasal glands from adult pigs for comparison with dose-
response relationships for adult pig tracheal glands obtained
previously by Choi et al. [27]. Both agonists showed increased
potency for nasal glands: the EC50 for carbachol was ,20% of
that observed previously for tracheal glands (114618 nM vs.
590616 nM), and the EC50 for forskolin was , 25% of that
observed previously for tracheal glands (16916135 nM vs.
663561836 nM), Figure 4A.
In adult pig glands carbachol’s potency and efficacy are greater than
forskolin’s (Figure 4A). Unexpecte d l y ,w ed i s c o v e r e dam a r k e d ,a g e -
dependent difference in the relative efficacy of carbachol and forskolin
in nasal glands of neonate vs. adult pigs. In neonatal piglet nasal glands,
1 mM carbachol stimulated a mean secretion rate ,18-fold greater
(P,0.02) than that produced by 3 mM forskolin, whereas in adult pigs
it was about 3-fold greater (Figure 4B). When the forskolin/carbachol
ratio was determined within individual neonatal and adult pigs, the
ratio was ,5-fold greater in adults (P,0.03; Figure 4C).
Carbachol-stimulated fluid secretion from nasal glands is
significantly reduced in CF piglets
To compare responses to carbachol in WT and CF nasal glands
more directly, we augmented our standard protocol by testing
carbachol alone at two concentrations. This avoided residual effects
Figure 2. Overview of submucosal glands from pig nasal turbinates. A and B, Examples of mucous bubbles formed under oil on the surface
of nasal turbinates after 5 min stimulation with 1 mM carbachol of WT (A) and CF (B) piglets. This type of measurement was used to determine the
number of functional nasal glands per unit area of surface shown in (C). C, The average number of functional nasal glands per mm
2 of surface did not
differ between control and CF piglets; values were 2963( 8W T+ 2 Hz piglets) vs. 3062 in 9 CF piglets (P=0.58, n.s.). D, Gland density as a function of
age and location. Nasal gland density is significantly greater than tracheal gland density (P,0.0001), and neonatal gland density is greater than adult
gland density (P,0.0001). Values per mm
2 were: neonatal turbinate: 29.4; neonatal trachea: 9.01; adult turbinate: 9.05; adult trachea: 1.33. E, Single
gland secretion rates were inversely related to gland density, being lowest in neonatal nasal glands and highest in adult tracheal glands. F–J,
Histology of nasal submucosal glands from WT neonate (F, I), CF neonate (G, J), and WT adult (H) pig (hematoxylin and eosin with periodic acid-
Schiff stain, x40 (F–H), x100 (I, J)). Scale bars: 0.5 mm (A, B, F, G, H); 0.1 mm (I, J).
doi:10.1371/journal.pone.0024424.g002
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stimulation protocol. In WT piglets (Figure 5A–C), 0.1 mM
carbachol increased secretion ,39-fold over basal rates (n=7, 84
glands, P,0.02). Responses of WT nasal glands to 0.1 and 1 mM
carbachol were 3.3 and 2.7 fold larger than corresponding CF
responses when comparing secretion rates over the entire 30 min
period of carbachol-stimulated secretion, (0.1 mM: n=7, 10
P,0.03; 1 mM: n=7, 9, P,0.02). Secretion to carbachol has a
large, transient component. When considering just the 15 min
period post-stimulation with 1 mM carbachol, the control responses
were also significantly larger than the CF responses (P,0.04; n=7,
9). When 1 mM carbachol was given at the end of the standard
stimulation protocol (Figure 5D), it stimulated nasal gland secretory
rates that were 3.6-fold greater in WT vs. CF piglets. (Figure 5E,
P,0.02). The distribution of individual gland responses for
carbachol-stimulated secretion in the standard protocol is shown
in Figure 5F.
Nasal glands of neonatal piglets did not show synergy
between forskolin and carbachol in the standard
protocol
In tracheal submucosal glands of humans [27,28], ferrets [42],
and neonatal pigs [38], combining low levels of [cAMP]i and
[Ca
2+]i elevating agonists produces fluid secretion that is greater
Figure 3. Defective forskolin-stimulated fluid secretion from CF piglet nasal glands. A, Plots of averaged nasal gland secretion rates from
8 control and 9 CF piglets stimulated with 3 mM forskolin. The response for each piglet was the average of from 8 to 17 glands. Significantly more
fluid was secreted at the first 5 min time point and at each subsequent point (t-test, * indicates P,0.05). B, Response to small carbachol stimulus
proves CF nasal glands are viable. Average secretion rates of 9 nasal glands from a 1 day old CF (-/-) piglet as a function of time and stimulation with
forskolin (3 and 10 mM) and carbachol (0.1 mM). C, Summary data for 10 control and 12 CF piglets (* indicates t-test P,0.003, { indicates paired t-test
P,0.006). Rates were averaged over the entire 30 min period of stimulation and the basal rate was subtracted from the forskolin-stimulated rates. If
rates are determined for only the last 20 min of stimulation (sustained rates) the rate is ,10% higher for forskolin and ,20% less for carbachol. The
response of CF glands to 3 mM forskolin did not differ significantly from zero. D, Mean response rates to 3 mM forskolin plotted separately for each
genotype. (* indicates t-test P,0.006, { indicates Mann-Whitney test P,0.03). E, Response rates for all glands tested, plotted separately for genotype;
horizontal bars indicate means.
doi:10.1371/journal.pone.0024424.g003
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in CF glands of humans [27,28] and pigs [38]. We included a test
for synergy in piglet nasal glands using the same protocol that
worked for piglet tracheal glands. However, as indicated in
Methods, the concentrations of carbachol and forskolin in the
standard protocol were non-optimal for demonstrating synergy.
Nasal glands are more sensitive than tracheal glands to carbachol
and forskolin, so the 0.1 mM dose of carbachol produced
significant secretion on its own (Figure 5A), as did the 3 mM
concentration of forskolin (Figure 2A). When combined, their
effects were additive, not synergistic, unlike the results in day-old
pig tracheal glands [38]. Further experiments will be required to
verify the apparent lack of synergy in the nasal turbinate glands.
Minimal secretory response of WT piglet nasal glands to
Substance P
The tachykinin Substance P (SubP) stimulates tracheal gland
secretion in humans [28], and pigs [43], but is a much better agonist
for pig glands. For trachealglandsSubPis,10 times moreefficacious
in pigs than in humans [28]; in pigs SubP is more potent than
Figure 4. Agonist sensitivities. A, Nasal glands are more sensitive than tracheal glands to both carbachol and forskolin. Dose-response plots for
carbachol (circles) and forskolin (square) in nasal glands (solid line, closed symbols) and tracheal glands (dotted line, open symbols) of adult pigs.
Tracheal gland responses are plotted on the left Y axis and nasal gland responses on the right Y axis; the two Y axes were adjusted to give
overlapping maximal response rates to carbachol. The carbachol dose-response for tracheal glands (dotted line, open circles) is from Choi et al., 2007
[27]. Each point represents average data from 33–80 glands in 3–7 pigs; doses were increased sequentially except for concentrations $3 mM forskolin
and $1 mM carbachol, where single doses were tested in each experiment to avoid desensitization and merging of bubbles. B, nasal gland secretion
rates of neonates and adults to carbachol and forskolin (*indicates paired t-test, P,0.02). C, The ratio of secretion rates to forskolin vs. carbachol was
significantly greater in adult than in neonatal pigs (t-test, * indicates P,0.02).
doi:10.1371/journal.pone.0024424.g004
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neonatal WT piglet nasal glands by modifying the standard protocol
so that SubP (1 mM) was added instead of 1 mM carbachol following
the 3 mM forskolin + carbachol 0.1 mM period. Surprisingly,
secretion rates dropped to near basal levels in the presence of SubP
after washout of forskolin + carbachol (Figure 6A). Figure 6B
compares the average secretion rates to 1 mM SubP and 1 mM
carbachol in 3 one-day old WT piglets;the secretion rate to carbachol
was significantly (,16-fold) greater than to SubP (P,0.004, paired t-
test). The low responsiveness to SubP could be an intrinsic feature of
nasal glands, or could have resulted from the young age of the piglets
or from loss of responsiveness during overnight shipping. Therefore
we tested nasal glands from four adult pigs obtained less than 2 hours
after euthanasia and confirmed that the response to SubP was only
,6 %o ft h er e s p o n s et oc a r b a c h o l( F i g u r e7 ) .
Summary of gland secretory responses in nasal and
tracheal glands of control and CF neonatal piglets
In Figure 8, secretion rates are shown for 6 stimulus conditions
(A-F) with each bar representing one of 4 types of gland: nasal and
tracheal from CF and control newborn piglets. Data for tracheal
responses were taken from Joo et al. [38]. Responses to all agonists
were significantly reduced in CF piglets except for SubP in nasal
glands (not testable because no response in WT, and carbachol in
tracheal glands (Figure 8B–D, F, P,0.05, t-test). WT nasal glands
showed significantly smaller secretion rates than tracheal glands to
all agonists except to 0.1 mM carbachol (Figure 8E), where the
greater response of the nasal gland is thought to result from the
higher potency to carbachol in nasal glands as shown in Figure 4A.
Discussion
CF vs. control glands
Nasal turbinate submucosal glands of one-day old CF piglets
display a profound decrease in stimulated fluid secretion. Secretion
to forskolin was absent, and secretion in response to carbachol
alone or in combination with forskolin was reduced (Figure 2, 4,
5). Thus nasal glands, like tracheal-bronchial glands in other
species, require CFTR for proper secretory function
[25,26,27,29,30,38,40,41,44,45,46,47,48]. These results occurred
Figure 5. Carbachol-stimulated secretion from CF nasal submucosal glands is reduced. All data are from a one day old WT pig. A,A
representative experiment plotting mucus volume as a function of time and stimulation with 0.1 mM carbachol for 12 nasal glands from a newborn WT
piglet.Thicker plot line andgray circle symbols indicateaveraged volume. B, Average secretion rates as a function of time and stimulation for 7 control and
9–10 CF piglets stimulated with 0.1 mM and then 1 mM carbachol. C, Summary data: 1 mM carbachol caused a significant increase is secretion from nasal
glands of both control and CF piglets; the response in CF piglets was significantly smaller than in control piglets ({ indicates Mann-Whitney test, P,0.03,
* indicates t-test, P,0.04). Secretion rates to 0.1 mM carbachol were (in pl/min/gland) control: 22.467.0 (n=7) and CF: 6.762.6 (n=10). Rates to 1 mM
carbacholwere control: 143.5635.5 (n=7)andCF was 52.2610.3 (n=9). D, Average nasal gland secretion rates as a function of time and stimulation for 10
control and 9–12 CF piglets stimulated sequentially with 3 mM forskolin, 3 mM Forskolin + 0.1 mM carbachol, and 1 mM carbachol. E, Mean basal and 1 mM
carbachol- stimulated secretory rates from experiment shown in (D). Bars represent the average secretion rates for the 30 min period following addition of
carbachol, the difference between this graph and (C) is that carbachol stimulation here directly followed forskolin stimulation after brief washout
(* indicates control vs. CF, t-test P,0.05, { indicates paired t-test P,0.03). F, Distribution of secretory rates for all glands in response to 1 mM carbachol.
doi:10.1371/journal.pone.0024424.g005
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observed in both -/- and DF508/DF508 genotypes, with partial
sparing in the DF508 genotype (Figure 3D, E). Partial sparing of
forskolin-mediated secretion in the DF508 phenotype is consistent
with evidence that porcine CFTR-DF508, expressed in various cell
lines or human epithelia, confers more residual function than
human CFTR-DF508 [49]. However, the amount of secretion
observed is not sufficient to preclude the development of a CF
phenotype, because CFTR
DF508/DF508 pigs develop a phenotype
like that of CFTR
-/- pigs and humans with CF [33]. The
occasional, very small secretory response to forskolin in CF
-/- nasal
glands (Figure 3E) must occur via a non-CFTR pathway—perhaps
via a forskolin elevation of [Ca
2+]i [50] that is on occasion
sufficient to weakly activate CaCC.
The response to carbachol was also decreased in CF piglets. We
have not yet measured the volumes of CF nasal glands with
sufficient accuracy to eliminate an interpretation that part of the
diminished response to carbachol reflects smaller gland volume.
However, inspection of sections stained with H&E did not reveal
obvious differences between CF and WT glands. Because similar
reductions in secretory rates have been observed in CF human
[30], ferret [40], and piglet glands [38], as well as in pig glands
treated with CFTRinh-172 [48], we think these differences reflect
the loss of CFTR-mediated fluid secretion.
Nasal vs. tracheal glands
We also documented functional differences between nasal and
tracheal glands. The sinonasal region of the upper respiratory tract
is separated from the trachea by the oropharynx and larynx.
Although some studies treat the two regions as equivalent, we
documented four differences between nasal and tracheal-bronchial
submucosal glands of the pig.
1) Nasal glands had smaller maximal secretory rates and more
densely distributed than tracheal glands (Figure 1). Nasal gland
secretion rates were, on average, about 30% of the rates of
tracheal glands but were ,3 times more numerous. The predicted
net result is that the volume of gland mucus secreted per a given
unit of surface area should be equivalent in that region of the
turbinates and in the trachea. For example, nasal gland secretion
Figure 6. Nasal glands of newborn piglets show minimal
secretory response to SubP. A, Averaged secretion rates as a
function of time and stimulation from one day old WT and CF piglets
(n=3 each). Note especially the lack of response to SubP in both groups.
B, Data from (A), replotted to show mean basal rates and rates to SubP
and carbachol. Mean rates for control (in pl/min/gland) were: basal:
1.861.3; SubP: 8.862.8; carbachol: 137.769.0, (* indicates P,0.0002,
n=3, paired t-test, for difference between responses to SubP and
carbachol. Meanrates for CF (inpl/min/gland) were: basal: 2.362.5; SubP:
1.561.8; carbachol: 55.4637.0, (n=3, paired t-test, P=0.228).
doi:10.1371/journal.pone.0024424.g006
Figure 7. Nasal glands of adult WT pigs show minimal
secretory response to SubP. A, Adult pig responses to SubP. Graph
of mucus volume as a function of time and stimulation for 12 glands in
fresh tissue from an adult pig. B, Images of mucus bubbles secreted
under oil from nasal turbinate mucosa of an adult pig after stimulation
with SubP for 20 min followed by carbachol for 5 min. C, Summary data
for 3–4 pigs; the responses to SubP did not differ significantly from
basal (paired t-test, P=0.375) and were significantly less than the
response to carbachol (t-test, P,0.02).
doi:10.1371/journal.pone.0024424.g007
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260.124 nl/min/
gl=3.66 nl/min for each mm
2 of turbinate surface. Tracheal
gland secretion would be 960.4 nl/min/gl=3.6 nl/min for each
mm
2 of tracheal surface. One nanoliter of fluid produces 1 mmo f
depth over a 1 mm
2 surface, so these numbers suggest that 2 min
of secretion would produce , 7 mm of fluid on either the nasal or
tracheal surfaces—a value considered to be sufficient for normal
mucociliary transport [51]. The situation in humans is the same.
When glands in nose, rhinopharynx, pharynx, hypopharynx and
trachea were compared the highest density occurred in the nose
and the lowest in the trachea—but tracheal glands were much
larger [52]. Within the cartilaginous airways, airway gland density
is a positive linear function of airway lumen diameter across
species [53,54]; in 4–8 week old pigs, glands were not found in
airways with an outer diameter smaller than 1 mm [55]. Almost
the same relationship is found for gland size and airway diameter
in human airways of different generations [56].
2) Pig nasal glands were almost unresponsive to Substance P
(Figure 6, 7). This low-responsiveness was unexpected because
SubP is a particularly potent and efficacious agonist for pig
tracheobronchial submucosal glands [28,43,57], and because of
evidence that it stimulates human nasal glands (see below). On
the other hand, there is abundant evidence for regional
differentiation within the respiratory epithelium e.g.
[1,58,59,60,61].
3) Carbachol and forskolin were more potent for nasal than for
tracheal glands. The carbachol and forskolin dose-response curves
were left-shifted in nasal glands relative to tracheal glands
(Figure 4).
These differences between turbinate and tracheobronchial
glands may presage further differences among glands within the
nasal cavity.
Neonate vs. adult nasal glands
We expected that secretory responses of nasal glands to agonists
would scale with gland size as animals grow. This was true for
carbachol-stimulated secretion, which was ,5-fold greater in adult
than neonate glands (Figure 2DvH). By contrast, secretion rates to
3 mM forskolin, which are CFTR-dependent (Figure 3) and refs
[26,38,40,41], were ,25-fold larger in adults, causing the ratio
between forskolin and carbachol-stimulated nasal gland secretion
to be 5-fold greater in adult than in neonate animals (Figure 4B,
C). We do not know the basis for the increasing magnitude of
CFTR-dependent secretion with age; it could be due to any




Differences between human and pig nasal glands
Pig tracheal glands are more sensitive than human glands to
SubP, [28,57], but pig nasal glands are unresponsive to SubP
(Figure 6, 7). What does SubP do to human nasal glands? Baraniuk
and colleagues provide evidence that human nasal glands respond
well to SubP [62]. They sprayed hypertonic saline into one nostril
and collected lavage fluids from both nostrils. Only the sprayed
nostril produced increased SubP, protein, lactoferrin, and
mucoglycoprotein markers, suggesting glandular stimulation via
local axon reflexes, consistent with abundant NK-1 receptor
mRNA in the nasal glands [62], see also [63]. Together, the results
suggest a four-way discordance in SubP sensitivity between pig
and human nasal and tracheal glands. In humans, SubP sensitivity
is high in nasal and low in tracheal glands, in pigs it is the reverse.
Implications for pathogenesis in pigs and humans
Sinonasal disease has not yet been reported in CF pigs, but the
CF piglet nasal epithelium has abnormal ion transport at birth
[32] and we now show it also has deficient gland fluid secretion. In
humans with CF, chronic rhinosinusitis (CRS) disease begins early
and almost universally [see ref [64] and references therein]. It
usually includes opacified sinuses, nasal polyps, and infections, and
it differs in several ways from CRS in non-CF subjects [65]. The
contribution of altered nasal gland secretion to human CF sinus
disease is unknown, but increasing evidence suggests that it
contributes to lung disease in CF patients [5,8,10], with sinonasal
flora acting as a reservoir for pulmonary infection [2,13].
In summary, these experiments reveal many features that distinguish
nasal turbinate glands from tracheal glands. They also discover an
unexpected increase in the relative role of forskolin-stimulated secretion
in older pigs. In spite of these differences, fluid secretion from nasal
glands in newborn or infant CFTR
-/- piglets is reduced to all
mediators, (with some sparing in CFTR
DF508/DF508 piglets), which will
compound the previously demonstrated defects in tracheal glands (43).
The nasal gland defects may compromise airway innate defenses at the
earliest point of contact between mucosa and pathogens.
Figure 8. Summary of secretory responses comparing control
vs. CF and nasal vs. tracheal glands in neonatal piglets. Data for
tracheal responses taken from Joo et al., [38]. A–F, Each graph shows
control (open bars) and CF (closed bars) secretory rates for nasal (left) or
tracheal (right) glands in response to the agents shown. * indicates t-
test P,0.05 for either WT vs. CF or nasal vs. tracheal. { indicates Mann-
Whitney test P,0.02. See text.
doi:10.1371/journal.pone.0024424.g008
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Pig nasal tissue
Piglets were offspring of CFTR
+/– or CFTR
+/DF508 pigs made
by homologous recombination in fibroblasts from outbred
domestic pigs and subsequent somatic cell nuclear transfer [32].
Piglets were genotyped as described in references [34] and [33].
The ages and genotypes of piglets (n=39) used for these
experiments are shown in Table 1. All animal procedures were
approved by the Institutional Animal Care and Use Committees of
the University of Iowa, Iowa City, IA 52242. Nasal turbinate
tissues (turbinate bone and overlying mucosa) were removed and
shipped from the University of Iowa in cold physiological saline
containing 10 mM glucose. Some nasal tissues purchased from
Exemplar Genetics (Iowa City, IA) were delivered in the same
manner. When possible, WT, Hz and CF samples from the same
litter were co-shipped. The interval between euthanasia and
experiments was 18–24 hrs. Nasal glands were also studied from 4
infant pigs (2 CF and 2 WT, 57–100 days old) and from 11 adult
pigs (all WT, age .4 months). Adult tissues were obtained , 1h r
postmortem (pentobarbital injection) following experiments car-
ried out for other purposes. No WT adult pigs were euthanized
specifically for these experiments; nevertheless, the experiments
were approved by Stanford University Institutional Animal Care
and Use Committee, Stanford, CA, 94305.
Optical measurement of mucus secretion rates (mucus
bubble method)
Secretion from individual glands was measured as described [66].
A piece of nasal turbinate mucosa ,1c m
2 was dissected from the
turbinate bone and mounted in a Sylgard-filled chamber with serosa
in the bath (pH 7.4 and ,290 mOsm Krebs-Ringer bicarbonate
buffer containing glucose and 1 mM indomethacin to minimize
prostaglandin release). The tissue surface was cleaned, dried, and
about 10 mL of water-saturated mineral oil was layered onto its
surface. Experiments were at 37uC ;t h et i s s u ew a ss u p e r f u s e dw i t h
warmed, humidified 95% O2–5% CO2.P h a r m a c o l o g i c a la g e n t s
were diluted to final concentration with warmed, gassed bath solution
and were added to the basolateral (serosal) side by complete bath
replacement. Bubbles of secreted mucus were visualized within the oil
layer by oblique illumination and digitally imaged with the macro
lens of a camera. Images were measured using ImageJ software
(http://rsb.info.nih.gov/ij/) and mucous volumes determined from
the size of the spherical bubbles. Secretion rates were determined at
5 min intervals, these were sometimes plotted directly in addition to
averaging rates over each experimental period (usually 30 min for
each treatment). This method slightly underestimates the long-term
rate of secretion to agonists like forskolin because it includes an initial
period before secretion reaches maximum;and overestimates the rate
to agonists like carbachol because it includes an initial rate of
transiently high secretion.
Gland density was measured by counting the number of mucus
bubbles after carbachol stimulation for 3 areas (totaling ,3m m
2)
randomly selected from within the region of maximal gland
density (see Figure 1). The variation (standard error) of these three
area of 1 mm
2 were 2.8 (newborn nasal, n=17), 1.6 (infant nasal,
n=4), and 0.6 (adult nasal, n=7). Counts (glands/mm
2) were
averaged for 8 WT and 9 CF neonate piglets, 2 WT and 2 CF
infant piglets, and 7 WT adult pigs.
Histology
WT (n=3) and CF (n=3) neonate piglet and WT adult (n=3)
nasal turbinates were used for histological study. All tissues were
fixed with 10% formaldehyde for 24 hours, dehydrated in an
alcohol series and stained with hematoxylin and eosin and also
with periodic acid-Schiff stain.
Stimulation protocol
For most experiments we used a standard protocol of agonist
addition designed to facilitate sequential testing of various
mediators on the small amounts of tissues available. The standard
protocol was: 1) a 20 min basal period, 2) 30 min of 3 mM
forskolin, 3) 30 min of 0.1 mM carbachol + 3 mM Forskolin, and 4)
1 mM carbachol. The 3 mM forskolin dose was a compromise. It
was chosen to be large enough to produce reproducible gland
stimulation mediated by increased [cAMP]i in control airways, but
small enough (it is , the EC50) to allow increases when combined
with small concentrations of carbachol in a synergy paradigm.
Carbachol at 0.1 mM is a near-threshold concentration for pig
tracheal glands and so was considered to be appropriate for the
synergy protocol, but as shown in the result section, 0.1 mM was
determined to be suprathreshold for nasal glands. Carbachol at
1 mM elevated [Ca
2+]i sufficiently to recruit Ca
2+-activated Cl
2
channels (CaCCs) and produce glandular secretion that was at
least partially CFTR-independent. A maximal concentration (,
3 mM) was avoided because the high level of secretion produced
caused rapid merging of the adjacent bubbles of mucus. Merging is
more of a problem in neonatal nasal tissue because of the high
density of submucosal glands in that tissue (see Figure 2A–D).
Reagents
Compounds (Sigma-Aldrich) were made fresh or maintained at
220uC as aliquots of stock solutions. Stock solutions of substance P
(SubP), phosphoramidon (a protease inhibitor used together with
substance P to prevent a potential breakdown of SubP), and
carbachol were dissolved in sterile distilled water; indomethacin
was in ethanol, and forskolin was in dimethyl sulfoxide (DMSO).
Drugs in the gland secretion experiments were diluted 1:1,000
with bath solution immediately before use at the concentrations
indicated. The highest DMSO concentration in our experiments
was 0.1%.
Statistics
Data are means6SEM, and Student’s two tailed t-test for
unpaired data was used to compare the means of different
Table 1. Summary of subjects used.
Genotype
Age
(days) n Mean age Total N




Neonate CF DF508/DF508 1 4 1.060.0 12
-/DF508 1 1
-/- 1 7
Infant Control +/+ 70 1 85621 2
+/+ 100 1
Infant CF -/DF508 57 1 59632
-/DF508 61 1
Adult Control +/+ .120 11 Unknown 11
doi:10.1371/journal.pone.0024424.t001
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tested with Levene’s F-test and Mann-Whitney test was also used
for unequal variations of groups. The difference between the two
means was considered to be significant when P,0.05.
Supporting Information
Figure S1 Histology of nasal submucosal (superficial)
glands from WT (upper panel) and CF (lower panel)
neonatal pig nasal turbinates (hematoxylin and eosin
with periodic acid-Schiff stain, x100). Scale bar; 0.1 mm.
(TIF)
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